Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia

Molecular Brain Research

Volumn 117, Issue 1, 2003, Pages 104-107

  Sazci, Ali ^a   Ergül, Emel ^a   Güzelhan, Yalçin ^b   Kaya, Güner ^b   Kara, Ihsan ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Association; Genotyping; MTHFR; Polymorphism; Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

EID: 0141448781     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00327-9     Document Type: Article

References (21)

1. Arinami T., Yamada N., Yamakawa-Kobayashi K., Hamaguchi H., Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am. J. Med. Genet. 74:1997;526-528.
2. Regland B., Germgard T., Gottfries C.G., Grenfeldt B., Koch-Schmidt A.C. Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J. Neural Transm. 104:1997;931-941.
3. Kunugi H., Fukuda R., Hattori M., Kato T., Tatsumi M., Sakai T., Hirose T., Nanko S. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol. Psychiatry. 3:1998;435-437.
4. Virgos C., Martorell L., Simo J.M., Valero J., Figuera L., Joven J., Labad A., Vilell E. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Neuroreport. 10:1999;2035-2038.
5. Joober R., Benkelfat C., Lal S., Bloom D., Labelle A., Lalonde P., Turecki G., Rozen R., Rouleau G.A. Association between the methylenetetra-hydrofolate reductase 677C→T missense mutation and schizophrenia. Mol. Psychiatry. 5:2000;323-326.
6. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetra-hydrofolate reductase (MTHFR). Thromb. Haemost. 78:1997;523-526.
7. Jones P.A., Gonzalgo M.L. Altered DNA methylation and genome instability: a new pathway to cancer? Proc. Natl. Acad. Sci. USA. 94:1997;2103-2105.
8. Friso R., Choi S.-W., Gireli D., Mason J.B., Dolnikowski G.G., Bagley P.J., Olivieri O., Jacques P.F., Rosenberg I.H., Corrocher R., Selhub J. A common mutation in the 5,10-methylenetetra-hydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA. 99:2002;5606-5611.
9. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301:1983;89-92.
10. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21:1999;163-167.
11. Robertson K.D., Wolffe A.P. DNA methylation in health and disease. Nat. Rev. Genet. 1:2000;11-19.
12. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
13. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. New Engl. J. Med. 338:1998;1042-1050.
14. Ueland P.M., Refsum H., Beresford S.A., Vollset S.E. The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 72:2000;324-332.
15. Gershoni-Baruch R., Dagan E., Israeli D., Kasinetz L., Kadouri E., Friedman E. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur. J. Cancer. 36:2000;2313-2316.
16. van der Put N.M., Gabreels F., Stevens E.M.B., Smeitink J.A.M., Trijbels F.J.M., Eskes T.K.A.B., van den Hauvel L.P., Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects? Am. J. Hum. Genet. 62:1998;1044-1051.
17. Botto D.L., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies. A HuGE review. Am. J. Epidemiol. 151:2000;862-877.
18. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64:1998;169-172.
19. Kara I., Sazci A., Ergul E., Kaya G., Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10-methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res. Mol. Brain Res. 111:2003;84-90.
20. Smith A.B., Peterson P., Wieland J., Moriarty T., DeLisi L.E. Chromosome 18 translocation (18; 21)(p11.1; p11.1) associated with psychosis in one family. Am. J. Med. Genet. 67:1996;560-563.
21. O. Demirhan, D. Tasdemir, Chromosomal aberrations in a schizophrenia population, Schizophr. Res., in press.